IP Library Assignment 062489/0829
Patent Assignment
Reel/Frame 062489/0829

Change of Name

Recorded: 2023-01-26 Pages: 7
Assignor
NOXXON PHARMA AG
Executed: 2002-07-11
Assignee
TME PHARMA AG
MAX-DOHRN-STR. 8-10, BERLIN, 10589, GERMANY
Covered Properties (18)
Novel Use of Spiegelmers
Patent: 9,074,214 →
Application: 13/953,797 →
Publication: US 2013/0337049
Sdf-1 Binding Nucleic Acids
Patent: 8,314,223 →
Application: 12/374,311 →
Publication: US 2011/0112172
SDF-1 Binding Nucleic Acids
Patent: 9,035,038 →
Application: 13/651,385 →
Publication: US 2013/0041019
SDF-1 Binding Nucleic Acids
Patent: 9,822,369 →
Application: 14/705,809 →
Publication: US 2015/0232853
SDF-1 Binding Nucleic Acids
Application: 17/092,390 →
Publication: US 2021/0139909
Mcp-1 Binding Nucleic Acids
Patent: 8,193,159 →
Application: 12/279,183 →
Publication: US 2010/0284961
MCP-1 binding nucleic acids
Patent: 8,691,784 →
Application: 13/487,341 →
Publication: US 2013/0035376
MCP-1 Binding Nucleic Acids
Patent: 9,670,491 →
Application: 14/246,134 →
Publication: US 2016/0208262
MCP-1 Binding Nucleic Acids
Application: 15/614,665 →
Publication: US 2018/0066265
SDF-1 Binding Nucleic Acids And The Use Thereof
Patent: 8,772,257 →
Application: 12/672,449 →
Publication: US 2011/0223127
SDF-1 Binding Nucleic Acids and the Use Thereof
Patent: 9,988,636 →
Application: 15/219,891 →
Publication: US 2016/0326531
Sdf-1 Binding Nucleic Acids and the Use Thereof in Cancer Treatment
Patent: 9,387,221 →
Application: 14/947,173 →
Publication: US 2016/0095875
Sdf-1 Binding Nucleic Acids and the Use Thereof in Cancer Treatment
Application: 15/201,477 →
Publication: US 2016/0355821
Methods for the Preparation of a Polyalkoxylated Nucleic Acid Molecule
Application: 15/116,050 →
Publication: US 2017/0166604
Means and Methods for the Treatment of Nephropathy
Application: 15/034,036 →
Publication: US 2017/0233737
Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors
Application: 16/093,645 →
Publication: US 2020/0071701
A Method for Polyalkoxylation of Nucleic Acids That Enables Recovery and Reuse of Excess Polyalkoxylation Reagent
Application: 16/464,291 →
Publication: US 2020/0291057
Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors
Application: 17/844,037 →
Publication: US 2023/0146246
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 15, 2008
From: PURSCHKE, WERNER; JAROSCH, FLORIAN; EULBERG, DIRK; KLUSSMANN, SVEN
To: NOXXON PHARMA AG
Reel/Frame 021981/0958 →
Assignment of Assignor's Interest Feb 6, 2009
From: PURSCHKE, WERNER; JAROSCH, FLORIAN; EULBERG, DIRK; KLUSSMANN, SVEN
To: NOXXON PHARMA AG
Reel/Frame 022216/0668 →
Assignment of Assignor's Interest Feb 19, 2010
From: PURSCHKE, WERNER; JAROSCH, FLORIAN; EULBERG, DIRK; KLUSSMANN, SVEN
To: NOXXON PHARMA AG
Reel/Frame 023966/0066 →
Security Interest Mar 13, 2014
From: NOXXON PHARMA AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 032422/0064 →
Security Interest Jun 2, 2014
From: NOXXON PHARMA AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033075/0616 →
Security Interest Jul 30, 2014
From: NOXXON PHARMA AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033448/0932 →
Security Interest Apr 27, 2015
From: NOXXON PHARMA AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 035501/0893 →
Security Interest May 27, 2015
From: NOXXON PHARMA AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 035715/0742 →
Security Interest May 27, 2015
From: NOXXON PHARMA AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 035715/0797 →
Security Interest Sep 2, 2015
From: NOXXON PHARMA AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 036527/0037 →
Security Interest Sep 2, 2015
From: NOXXON PHARMA AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 036527/0127 →
Security Interest Aug 9, 2016
From: NOXXON PHARMA AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 039632/0101 →
Security Interest Aug 9, 2016
From: NOXXON PHARMA AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 039632/0001 →
Assignment of Assignor's Interest Sep 2, 2016
From: BETHGE, LUCAS
To: NOXXON PHARMA AG
Reel/Frame 039905/0664 →
Assignment of Assignor's Interest Sep 25, 2017
From: EULBERG, DIRK; BAUMANN, MATTHIAS
To: NOXXON PHARMA AG
Reel/Frame 043676/0399 →
Assignment of Assignor's Interest May 27, 2019
From: BETHGE, LUCAS
To: NOXXON PHARMA AG
Reel/Frame 049287/0267 →
Release of Security Interest Feb 7, 2020
From: KREOS CAPITAL IV (UK) LIMITED
To: NOXXON PHARMA AG
Reel/Frame 051757/0649 →
Assignment of Assignor's Interest Nov 29, 2022
From: VATER, AXEL; ZBORALSKI, DIRK
To: NOXXON PHARMA AG
Reel/Frame 061897/0728 →
Assignment of Assignor's Interest Jul 23, 2025
From: TME PHARMA AG
To: APTARION BIOTECH AG
Reel/Frame 071801/0567 →